aTyr Pharma Raises $10.5M

San Diego-based aTyr Pharma, a biopharmaceutical firm focused on protein biologics for human therapeutics, said this morning that it has raised $10.5M in a Series B funding. The round was led by Alta Partners and Polaris Venture Partners. Other investors in the company included Imagene and Cardinal Partners. As part of the funding, David Mack of Alta and Amir Nasaht of Polaris have joined the company's board. The new round of funding will go towards research and development efforts and expansion of the company's management and operations. More information »